Ingredion Inc . (NYSE:INGR), a leading global ingredient solutions provider, has been navigating a complex market environment ...
Artificial intelligence (AI) can rapidly screen patients for clinical trial enrollment, according to a new study published in JAMA and led by Mass General Brigham researchers. Their novel AI-assisted ...